Fact CheckerSign in

NCT05982717Completed

A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain

Epidemiology of Dravet and Lennox-Gastaut Syndromes in Spain

Source: ClinicalTrials.gov · Last updated 18 Aug 2026

Brief summary (registry, in English)

The main aims of this study are to gather information about how many children, teenagers and adults in Spain have been diagnosed with Dravet syndrome and Lennox-Gastaut syndrome as well as to learn about the number of new Dravet syndrome and Lennox-Gastaut syndrome cases in persons in Spain. Participants' data will be taken from their medical records (charts), which were already collected as a part of their routine care in public hospitals in Spain between 01 January 2021 and 31 December 2022.

Status (registry)
Completed
Study type
Observational
Enrollment
237 (actual)
First submitted
28 Jul 2023
Start date
26 Oct 2023
Primary completion date
9 Apr 2025
Lead sponsor
Takeda
Diseases
Epilepsy
NCT number
NCT05982717

What you commit to

  • Study type: Observational
  • Participants enrolled: 237
  • From 26 Oct 2023 to the primary completion date, 9 Apr 2025
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participants with epileptic condition other than DS or LGS.

Other

  • Participants with DS or LGS not residents in the reference area of the hospital.

Who the study is looking for

  • Diagnosis criteria for DS:
  • All the following criteria must be met: i. Seizures onset within 1-20 months (usually within the first year of life). ii. Normal initial development prior to presentation (no cognitive or behavioural disability before the onset of seizures) followed by behaviour and cognitive impairment.
  • Recurrent focal clonic (hemiclonic) febrile and afebrile seizures (which often alternate sides from seizure to seizure), focal to bilateral tonicclonic, and/or generalized clonic seizures.
  • And at least one of the following criteria must be met: i. Emergence of other seizure type, including atypical absence seizures, myoclonic seizures, atonic seizures, or non-tonic-clonic status epilepticus between 1-4 years.
  • Seizures triggered by fever due to illness or vaccinations, hot baths, sudden temperature changes, high level of activity, or by strong lighting or exposure to certain visual patterns.
  • Mutations or copy number variants in the SCN1A gene.
  • Diagnosis criteria for LGS:
    • Given the uncertainties associated with the diagnosis of this condition, two different criteria will be used, a stricter criterion, intended to identify "pure" Lennox-Gastaut syndrome participants, and a wider criterion, intended to also include the so-called Lennox-Gastaut-like participants.
    • Lennox-Gastaut syndrome - stricter criteria:
  • All the following criteria must be met: i. Seizures onset before 18 years of age, typically from 1 to 8 years. ii. Progressive development/cognition impairment after seizures onset. iii. Tonic seizures. iv. At least one additional seizure: generalised tonic-clonic seiures, atypical absence seizures, atonic seizures, myoclonic seizures, focal impaired awareness, epileptic spams, or non-convulsive status epilepticus v. Slow (\<2.5 hertz \[Hz\]) spike-and-wave EEG pattern. vi. Paroxysmal fast activity (10 Hz or greater) in sleep.
    • Lennox-Gastaut syndrome - wider criteria:
  • At least one the following criteria must be met:
    • Tonic seizures. ii. Multiple types of seizures, including generalised tonic-clonic seizures, atypical absence seizures, atonic seizures, myoclonic seizures, myoclonic-atonic seizures, focal seizures, epileptic spams, or nonconvulsive status epilepticus.
  • And at least one the following criteria must be met:
    • Slow (\<2.5 Hz) spike-and-wave EEG pattern. ii. Paroxysmal fast activity (10 Hz or greater) in sleep.
  • And at least two of the following criteria must be met:
    • Seizures onset before 18 years of age, typically from 1 to 8 years. ii. Progressive development/cognition impairment after seizures onset. iii. Development/cognition impairment starts prior to seizures onset. iv. History of Infantile epileptic spasms syndrome (IESS), West or Ohtahara syndromes.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
H. Universitario Infantil Niño Jesús
Coordinator of this site? Confirm its status
MadridSpainUnknown status
H. Universitario La Paz
Coordinator of this site? Confirm its status
MadridSpainUnknown status
Hospital Universitari i Politécnic La Fe
Coordinator of this site? Confirm its status
ValenciaSpainUnknown status
Complejo Hospitalario Universitario de Vigo
Coordinator of this site? Confirm its status
VigoSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.